September 2024 - Foresight Newsletter

SEPTEMBER 2024

EDITION 34

NSLHD Clinical Audit Schedule

Clinical Governance Standard The NSLHD Clinical Audit Schedule supports all sites and services within NSLHD to monitor and evaluate clinical care processes and informs clinical quality improvement activities across NSLHD. Download the complete 2024-2025 NSLHD Clinical Audit Schedule from the Clinical Audit Schedule Intranet page Clinical audits required to be completed this month are listed below.

September QARS Audits ( direct links available from Clinical Audit Intranet page)

NSLHD_03_Aseptic Technique NSLHD_03_Perioperative sharps management_2024 (RNSH Ambulatory Care | RNSH ASB OT / Anaesthetics | HKH OT | Ryde OT

Standard 3

NSLHD_05_Cognitive Impairment Audit (Delirium)

Standard 5

NSLHD_06_Clinical Handover - Nursing and Midwifery BEDSIDE Shift-to-Shift (MVH | HKH | RNSH | Ryde )

Standard 6

NSLHD_06_Clinical Handover -all Clinical Disciplines NSLHD_06_ Consent Audit (MVH | HKH | RNSH | Ryde )

NSLHD_08_MONTHLY_Resuscitation trolley/backpack and Resuscitaire equipment audit (RNSH | HKH MVH | RYDE | MHDA | HITH) NSLHD_08_BIANNUAL_Resuscitation trolley/backpack & Resuscitaire equipment Audit

Standard 8

Policies, Procedures and Guidelines Click on the links below to download documents from the Prompt document system. Refer to the NSLHD weekly bulletin to access the most up-to-date list of PPGs NSLHD_05_ Perioperative Patient Positioning

For any queries relating to policy, procedure and guideline development contact NSLHD-Policies@health.nsw.gov.au

NSLHD – Recently Published Policies, Procedures, Guidelines and Standing Orders

Perinatal Infections Management - NSLHD_Guideline Infliximab Intravenous: Adult Medication Protocol Acute Behavioural Disturbance Procedure, Safe Haven, NSLHD

Emergency Services Accessing Clinical Information from MHDA Services during High Risk Situations Maternity – Breastfeeding Principles for Protecting, Promoting and Supporting - NSLHD Laser Safety in the Perioperative Environment in NSLHD Administration of Alemtuzumab (Lemtrada®) for Multiple Sclerosis in the Medical Day Procedure Unit, Ambulatory Care Centre – RNSH

Safety Alerts - New, updated and recently published

Medication Safety Updates including medication shortages are available on the CEC website.

Made with FlippingBook - professional solution for displaying marketing and sales documents online